Shan Jiang

14PUBLICATIONS
14CO-AUTHORS
Cross-sectional analysisCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseHaematologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 16, 2025
Aggregate distributional cost-effectiveness analysis: a novel tool for health economic evaluation to inform resource allocation.

Shan Jiang, Boyang Li, Bonny Parkinson

|Jan 08, 2025
Cost-effectiveness of toripalimab plus chemotherapy versus chemotherapy as first-line treatment for advanced non-small cell lung cancer in China: a societal perspective.

Dai Lian, Yi Yang, Yuling Gan

|Sep 26, 2024
Synthesized economic evidence on the cost-effectiveness of screening familial hypercholesterolemia.

Mengying Wang, Shan Jiang, Boyang Li

|Mar 13, 2024
Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies".

Limin Wang, Shimeng Liu, Shan Jiang

|Jan 11, 2024
Prophylactic Interventions for Hereditary Breast and Ovarian Cancer Risks and Mortality in BRCA1/2 Carriers.

Taoran Liu, Jing Yu, Yangyang Gao

|Jul 31, 2023
Gauging Incentive Values and Expectations (G.I.V.E.) among Blood Donors for Nonmonetary Incentives: Developing a Preference Elicitation Instrument through Qualitative Approaches in Shandong, China.

Yu Wang, Peicong Zhai, Yue Zhang

Pageof 3

Frequent Collaborators

4 joint publications

Yawen Jiang

3 joint publications

Shunping Li

2 joint publications

Yuanyuan Gu

2 joint publications

Limin Wang